K2 Bio Partners III L.P. — Form D
K2 Bio Partners III L.P. of Grand Cayman, E9, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-05-06. The offering totals $150.0M, of which $30.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-05-06
- Form: D
- Accession: 0002066413-25-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $150.0M
- Amount sold: $30.5M
- Remaining: $119.5M
- Investors: 3
- Date of first sale: 2025-04-24
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-545331
Issuer
- Name: K2 Bio Partners III L.P.
- CIK: 0002066413
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2024
- Address: C/O WALKERS CORPORATE LIMITED, Grand Cayman, E9, KY1-9008
- Phone: 1 345 949 0100
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Keyi NA Chen | Promoter | Grand Cayman, E9 |
| N/A NA K2 Bio Partners III GP Limited | Promoter | Grand Cayman, E9 |
| Rui NA Zhang | Promoter | Grand Cayman, E9 |
More